Cargando…
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
BACKGROUND: Identification of BRCA mutation carriers among patients with breast cancer (BC) involves costs and gains. Testing has been performed according to international guidelines, focusing on family history (FH) of breast and/or ovarian cancer. An alternative is testing all patients with BC empl...
Autores principales: | Norum, Jan, Grindedal, Eli Marie, Heramb, Cecilie, Karsrud, Inga, Ariansen, Sarah Louise, Undlien, Dag Erik, Schlichting, Ellen, Mæhle, Lovise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905828/ https://www.ncbi.nlm.nih.gov/pubmed/29682331 http://dx.doi.org/10.1136/esmoopen-2018-000328 |
Ejemplares similares
-
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
por: Grindedal, Eli Marie, et al.
Publicado: (2017) -
BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
por: Heramb, Cecilie, et al.
Publicado: (2018) -
Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
por: Grindedal, Eli Marie, et al.
Publicado: (2020) -
“It was an important part of my treatment”: a qualitative study of Norwegian breast Cancer patients’ experiences with mainstreamed genetic testing
por: Strømsvik, Nina, et al.
Publicado: (2022) -
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
por: Heramb, Cecilie, et al.
Publicado: (2015)